Search for Clinical Trial Results

Sponsored By

Prurigo - 4 Studies Found

Status Study
Completed Study Name: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
Condition: Prurigo Nodularis
Date: 2007-07-26
Interventions:
  • Drug: Pimecrolimus twice daily
Completed Study Name: Topical Aprepitant in Prurigo Patients
Condition: Pruritus
Date: 2013-09-18
Interventions:
  • Drug: Aprepitant Aprepitant ge
RECRUITING Study Name: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Condition: Prurigo
Date: 2024-12-08
Interventions: Ruxolitinib cream 1.5% twice daily (BID) during the vehicle controlled (DBVC)and open label treatment period (OLE).
RECRUITING Study Name: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Condition: Prurigo Nodularis
Date: 2024-12-08
Interventions: Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period.